Delivery Order SPE2DB22D1202-SPE2DB25FVHD3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,916.54 to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 20 mg capsules (90-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $1,858.83 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count unit). This is a firm fixed-price contract with an ultimate completion date of July 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating the contract was competitively awarded. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) with a ceiling value of $12,297.40. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract performance location is in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, with an ultimate completion date of July...
- The Defense Logistics Agency awarded a delivery order valued at $2,533.09 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) on August 7, 2025, with completion targeted for August 8, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,942.94 to AmerisourceBergen Drug Corp for the supply of esomeprazole magnesium delayed-release 40 mg capsules (30-count units). This order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a firm fixed-price contract with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) with a contract value of $1,660.95. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a non-competitive set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) with a firm fixed price ceiling value of $5,752.28. The award was issued on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitive delivery order, which carries no set-aside designation, represents a purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count units) under a firm fixed-price contract valued at $51,984.29. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This contract award was not set aside and was competitively awarded,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) with a ceiling value of $1,199.22. This contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for ultimate completion by July 31, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to the AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Esomeprazole Magnesium Delayed-Release capsules. The $1,338.91 fixed-price contract has an ultimate completion date of August 8, 2024. AmerisourceBergen will provide these prescription medications to support military treatment facilities and other government healthcare programs. This delivery order is part of a larger Indefinite...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVHD3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,265.63 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Esomeprazole Magnesium Delayed Release 20 mg capsules (90-count units). This is a firm fixed price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 13, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to deliver a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that has demonstrated capability to meet competitive procurement requirements across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio reflects extensive experience delivering pharmaceutical products across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies through the DLA's Medical Supply Chain. The esomeprazole procurement supports the company's role as a primary pharmaceutical vendor for military and veteran healthcare logistics, contributing to the broader effort to maintain adequate medical inventory for Department of Defense operations and personnel.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 8/12/25 |